{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:38:36Z","timestamp":1793813916141,"version":"4.6.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Multi-system inflammatory syndrome in children (MIS-C) is a severe post-acute sequela of SARS-CoV-2 infection in children, and there is a critical need to unfold its highly heterogeneous disease patterns. Our objective was to characterize the illness spectrum of MIS-C for improved recognition and management. We conducted a retrospective cohort study using data from March 1, 2020\u2013September 30, 2022, in 8 pediatric medical centers from PEDSnet. We included 1139 children hospitalized with MIS-C and used their demographics, symptoms, conditions, laboratory values, and medications for analyses. We applied heterogeneity-adaptive latent class analyses and identified three latent classes. We further characterized the sociodemographic and clinical characteristics of the latent classes and evaluated their temporal patterns. Class 1 (47.9%) represented children with the most severe presentation, with more admission to the ICU, higher inflammatory markers, hypotension\/shock\/dehydration, cardiac involvement, acute kidney injury and respiratory involvement. Class 2 (23.3%) represented a moderate presentation, with 4\u20136 organ systems involved, and some overlapping features with acute COVID-19. Class 3 (28.8%) represented a mild presentation. Our results indicated that MIS-C has a spectrum of clinical severity ranging from mild to severe and the proportion of severe or critical MIS-C decreased over time.<\/jats:p>","DOI":"10.1038\/s41598-023-47655-y","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T20:01:37Z","timestamp":1701201697000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Spectrum of severity of multisystem inflammatory syndrome in children: an EHR-based cohort study from the RECOVER program"],"prefix":"10.1038","volume":"13","author":[{"given":"Suchitra","family":"Rao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naimin","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitaly","family":"Lorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Maltenfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Schuchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanieh","family":"Razzaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuncion","family":"Mejias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan M.","family":"Pajor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant S.","family":"Schulert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Thacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Jhaveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri A.","family":"Christakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Charles","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,28]]},"reference":[{"key":"47655_CR1","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/S0140-6736(20)31103-X","volume":"395","author":"L Verdoni","year":"2020","unstructured":"Verdoni, L. et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV 2 epidemic: An observational cohort study. Lancet 395, 1771\u20131778 (2020).","journal-title":"Lancet"},{"key":"47655_CR2","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(20)31094-1","volume":"395","author":"S Riphagen","year":"2020","unstructured":"Riphagen, S., Gomez, X., Gonzalez-Martinez, C., Wilkinson, N. & Theocharis, P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 395, 1607\u20131608 (2020).","journal-title":"Lancet"},{"key":"47655_CR3","unstructured":"Centers for Disease Control and Prevention. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19). https:\/\/emergency.cdc.gov\/han\/2020\/han00432.asp (2020)."},{"key":"47655_CR4","doi-asserted-by":"publisher","first-page":"E340","DOI":"10.1097\/INF.0000000000002888","volume":"39","author":"A Kaushik","year":"2020","unstructured":"Kaushik, A., Gupta, S., Sood, M., Sharma, S. & Verma, S. A systematic review of multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection. Pediatr. Infect. Dis. J. 39, E340\u2013E346 (2020).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"47655_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa2021756","volume":"383","author":"EM Dufort","year":"2020","unstructured":"Dufort, E. M. et al. Multisystem inflammatory syndrome in children in New York State. N. Engl. J. Med. 383, 347\u2013358 (2020).","journal-title":"N. Engl. J. Med."},{"key":"47655_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11882-022-01031-4","volume":"22","author":"JM Patel","year":"2022","unstructured":"Patel, J. M. Multisystem inflammatory syndrome in children (MIS-C). Curr. Allergy Asthma Rep. 22, 53\u201360 (2022).","journal-title":"Curr. Allergy Asthma Rep."},{"key":"47655_CR7","unstructured":"Center for Disease Control and Prevention. COVID Data Tracker. Health department-reported cases of multisystem inflammatory syndrome in children (MIS-C) in the United States. https:\/\/stacks.cdc.gov\/view\/cdc\/106439"},{"key":"47655_CR8","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1056\/NEJMoa2021680","volume":"383","author":"LR Feldstein","year":"2020","unstructured":"Feldstein, L. R. et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N. Engl. J. Med. 383, 334\u2013346 (2020).","journal-title":"N. Engl. J. Med."},{"key":"47655_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jpeds.2021.06.002","volume":"237","author":"RL DeBiasi","year":"2021","unstructured":"DeBiasi, R. L. et al. Multisystem Inflammatory syndrome of children: Subphenotypes, risk factors, biomarkers, cytokine profiles, and viral sequencing. J. Pediatr. 237, 125-135.e18 (2021).","journal-title":"J. Pediatr."},{"key":"47655_CR10","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1001\/jamapediatrics.2022.2800","volume":"176","author":"S Rao","year":"2022","unstructured":"Rao, S. et al. Clinical features and burden of postacute sequelae of SARS-CoV-2 infection in children and adolescents. JAMA Pediatr. 176, 1000\u20131009 (2022).","journal-title":"JAMA Pediatr."},{"key":"47655_CR11","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1136\/amiajnl-2014-002743","volume":"21","author":"CB Forrest","year":"2014","unstructured":"Forrest, C. B. et al. PEDSnet: A national pediatric learning health system. J. Am. Med. Inform. Assoc. 21, 602\u2013606 (2014).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"47655_CR12","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1377\/hlthaff.2014.0127","volume":"33","author":"CB Forrest","year":"2014","unstructured":"Forrest, C. B., Margolis, P., Seid, M. & Colletti, R. B. PEDSnet: How a prototype pediatric learning health system is being expanded into a national network. Health Aff. (Millwood) 33, 1171\u20131177 (2014).","journal-title":"Health Aff. (Millwood)"},{"key":"47655_CR13","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/gepi.1370110402","volume":"11","author":"B Melton","year":"1994","unstructured":"Melton, B., Liang, K.-Y. & Pulver, A. E. Extended latent class approach to the study of familial\/sporadic forms of a disease: Its application to the study of the heterogeneity of schizophrenia. Genet. Epidemiol. 11, 311\u2013327 (1994).","journal-title":"Genet. Epidemiol."},{"key":"47655_CR14","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1080\/01621459.1997.10473658","volume":"92","author":"K Bandeen-Roche","year":"1997","unstructured":"Bandeen-Roche, K., Miglioretti, D. L., Zeger, S. L. & Rathouz, P. J. Latent variable regression for multiple discrete outcomes. J. Am. Stat. Assoc. 92, 1375 (1997).","journal-title":"J. Am. Stat. Assoc."},{"key":"47655_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v042.i10","volume":"42","author":"DA Linzer","year":"2011","unstructured":"Linzer, D. A. & Lewis, J. B. poLCA: An R package for polytomous variable latent class analysis. J. Stat. Softw. 42, 1\u201329 (2011).","journal-title":"J. Stat. Softw."},{"key":"47655_CR16","unstructured":"GitHub\u2014dlinzer\/poLCA: Polytomous Variable Latent Class Analysis (R package). https:\/\/github.com\/dlinzer\/poLCA"},{"key":"47655_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1542\/hpeds.2016-0173","volume":"7","author":"TD Simon","year":"2017","unstructured":"Simon, T. D., Cawthon, M. L., Popalisky, J. & Mangione-Smith, R. Development and validation of the pediatric medical complexity algorithm (PMCA) version 2.0. Hosp. Pediatr. 7, 373\u2013377 (2017).","journal-title":"Hosp. Pediatr."},{"issue":"7","key":"47655_CR18","first-page":"790","volume":"1","author":"R Kolde","year":"2015","unstructured":"Kolde, R. & Kolde, M. R. Package \u2018pheatmap\u2019. R Package 1(7), 790 (2015).","journal-title":"R Package"},{"key":"47655_CR19","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1001\/jama.2020.2278","volume":"324","author":"M Mori","year":"2020","unstructured":"Mori, M., Krumholz, H. M. & Allore, H. G. Using latent class analysis to identify hidden clinical phenotypes. JAMA 324, 700\u2013701 (2020).","journal-title":"JAMA"},{"key":"47655_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.0081-1750.2003.t01-1-00131.x","volume":"33","author":"JK Vermunt","year":"2003","unstructured":"Vermunt, J. K. Multilevel latent class models. Sociol. Methodol. 33, 213\u2013239 (2003).","journal-title":"Sociol. Methodol."},{"issue":"4","key":"47655_CR21","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.csda.2004.11.004","volume":"50","author":"CC Yang","year":"2006","unstructured":"Yang, C. C. Evaluating latent class analysis models in qualitative phenotype identification. Comput. Stat. Data Anal. 50(4), 1090\u20131104 (2006).","journal-title":"Comput. Stat. Data Anal."},{"key":"47655_CR22","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.15585\/mmwr.mm6932e2","volume":"69","author":"S Godfred-Cato","year":"2020","unstructured":"Godfred-Cato, S. et al. COVID-19-associated multisystem inflammatory syndrome in children\u2014United States, March\u2013July 2020. MMWR Morb. Mortal. Wkly. Rep. 69, 1074\u20131080 (2020).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"47655_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/PCC.0000000000002850","volume":"23","author":"S Basu","year":"2022","unstructured":"Basu, S. et al. Strain echocardiography and myocardial dysfunction in critically ill children with multisystem inflammatory syndrome unrecognized by conventional echocardiography: A retrospective cohort analysis. Pediatr. Crit. Care Med. 23, 145\u2013152 (2022).","journal-title":"Pediatr. Crit. Care Med."},{"key":"47655_CR24","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-051155","volume":"148","author":"KM Farooqi","year":"2021","unstructured":"Farooqi, K. M. et al. Longitudinal outcomes for multisystem inflammatory syndrome in children. Pediatrics 148, e2021051155 (2021).","journal-title":"Pediatrics"},{"key":"47655_CR25","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.idc.2022.01.005","volume":"36","author":"EJ Chow","year":"2022","unstructured":"Chow, E. J. & Englund, J. A. Severe acute respiratory syndrome coronavirus 2 infections in children. Infect. Dis. Clin. North Am. 36, 435\u2013479 (2022).","journal-title":"Infect. Dis. Clin. North Am."},{"key":"47655_CR26","doi-asserted-by":"publisher","first-page":"E513","DOI":"10.1503\/cmaj.210873","volume":"194","author":"J Merckx","year":"2022","unstructured":"Merckx, J. et al. Predictors of severe illness in children with multisystem inflammatory syndrome after SARS-CoV-2 infection: A multicentre cohort study. CMAJ 194, E513\u2013E523 (2022).","journal-title":"CMAJ"},{"key":"47655_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.820229","volume":"10","author":"MA Fremed","year":"2022","unstructured":"Fremed, M. A. & Farooqi, K. M. Longitudinal outcomes and monitoring of patients with multisystem inflammatory syndrome in children. Front. Pediatr. 10, 820229 (2022).","journal-title":"Front. Pediatr."},{"key":"47655_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100527","volume":"26","author":"M Ahmed","year":"2020","unstructured":"Ahmed, M. et al. Multisystem inflammatory syndrome in children: A systematic review. EClinicalMedicine 26, 100527 (2020).","journal-title":"EClinicalMedicine"},{"issue":"1","key":"47655_CR29","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3390\/v15010180","volume":"15","author":"PO Kenney","year":"2023","unstructured":"Kenney, P. O., Chang, A. J., Krabill, L. & Hicar, M. D. Decreased clinical severity of pediatric acute COVID-19 and MIS-C and increase of incidental cases during the omicron wave in comparison to the delta wave. Viruses 15(1), 180 (2023).","journal-title":"Viruses"},{"issue":"24","key":"47655_CR30","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1001\/jama.2022.8025","volume":"327","author":"N Levy","year":"2022","unstructured":"Levy, N. et al. Severity and incidence of multisystem inflammatory syndrome in children during 3 SARS-CoV-2 pandemic waves in Israel. JAMA 327(24), 2452\u20132454 (2022).","journal-title":"JAMA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47655-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47655-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47655-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T20:02:08Z","timestamp":1701201728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47655-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,28]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["47655"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-47655-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,28]]},"assertion":[{"value":"22 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Mejias reports funding from Janssen, Merck for research support, and Janssen, Merck and Sanofi-Pasteur for Advisory Board participation; Dr. Rao reports prior grant support from GSK and Biofire. Dr. Chen receives consulting support from GSK. Dr. Jhaveri is a consultant for AstraZeneca, Seqirus and Dynavax, and receives an editorial stipend from Elsevier. All other authors have no conflicts of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21005"}}